Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Removing Barriers to Colorectal Cancer Screening Act of 2020
Client: DIGESTIVE HEALTH PHYSICIANS ASSOCIATION, INC. · Firm: THE MCMANUS GROUP
H.R. 1570 / S. 668 - Removing Barriers to Colorectal Cancer Screening Act of 2019. Opposition to H.R. 2143 - Promoting Integrity in Medicare Act of 2019. Support for H.R. 2282 / S. 966 Medicare Care Coordination Improvement Act of 2019. Opposition to step therapy requirement in Medicare Advantage. Support of proposed rules, Medicare Program; Modernizing and Clarifying the Physician Self-Referral Regulations (84 FR 55766) and Medicare and State Healthcare Programs: Fraud and Abuse; Revisions to Safe Harbors Under the Anti-Kickback Statute, and Civil Monetary Penalty Rules Regarding Beneficiary Inducements (84 FR 55694). S. 2543, the Prescription Drug Pricing Reduction Act of 2019, sec. 102; and S. 3129/H.R. 19, the Lower Costs, More Cures Act of 2019. The Public Health and Social Services Emergency Fund in H.R. 748, the CARES Act, and S. 3559/H.R. 6365, the Immediate Relief for Rural Facilities and Providers Act.
Removing Barriers to Colorectal Cancer Screening Act of 2020
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
NATIONAL ASSOCIATION OF FREESTANDING EMERGENCY CENTERS (NAFEC) via THE MCMANUS GROUP
2020 · third_quarter · 3A
Requirements related to COVID-19 testing. Surprise billing reform, including S. 1895, the Lower Health Care Costs Act, H.R. 3630, the No Surprises Act, H.R. 5826, the Consumer Protections Against Surprise Medical Bills Act, and H.R. 5800, the Ban Surprise Bills Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Source: Senate LDA
| WEX HEALTH |
| 6 |
| 2019–2020 |
| LARGE UROLOGY GROUP PRACTICE ASSOCIATION | 5 | 2018–2019 |
| ACHAOGEN | 3 | 2018 |
| AMBULATORY SURGERY CENTER ASSOCIATION | 3 | 2020 |
| AMERICAN LUNG ASSOCIATION | 2 | 2018 |
| AMERICAN OCCUPATIONAL THERAPY ASSOCIATION | 2 | 2020 |
| IVX HEALTH | 2 | 2020 |
| NATIONAL ASSOCIATION OF SPECIALTY PHARMACY (NASP) | 2 | 2017 |
| EMD SERONO, INC. | 1 | 2018 |
| PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | 1 | 2020 |
| zimmer biomet | 1 | 2020 |
Client: DIGESTIVE HEALTH PHYSICIANS ASSOCIATION, INC. · Firm: THE MCMANUS GROUP
H.R. 1570 / S. 668 - Removing Barriers to Colorectal Cancer Screening Act of 2019. Opposition to H.R. 2143 - Promoting Integrity in Medicare Act of 2019. Support for H.R. 2282 / S. 966 Medicare Care Coordination Improvement Act of 2019. Opposition to step therapy requirement in Medicare Advantage. Support of proposed rules, Medicare Program; Modernizing and Clarifying the Physician Self-Referral Regulations (84 FR 55766) and Medicare and State Healthcare Programs: Fraud and Abuse; Revisions to Safe Harbors Under the Anti-Kickback Statute, and Civil Monetary Penalty Rules Regarding Beneficiary Inducements (84 FR 55694). S. 2543, the Prescription Drug Pricing Reduction Act of 2019, sec. 102; and S. 3129/H.R. 19, the Lower Costs, More Cures Act of 2019. The Public Health and Social Services Emergency Fund in H.R. 748, the CARES Act.
Removing Barriers to Colorectal Cancer Screening Act of 2020
Client: DIGESTIVE HEALTH PHYSICIANS ASSOCIATION, INC. · Firm: THE MCMANUS GROUP
H.R. 1570 / S. 668 - Removing Barriers to Colorectal Cancer Screening Act of 2019. Opposition to H.R. 2143 - Promoting Integrity in Medicare Act of 2019. Support for H.R. 2282 / S. 966 Medicare Care Coordination Improvement Act of 2019. Opposition to step therapy requirement in Medicare Advantage. Support of proposed rules, Medicare Program; Modernizing and Clarifying the Physician Self-Referral Regulations (84 FR 55766) and Medicare and State Healthcare Programs: Fraud and Abuse; Revisions to Safe Harbors Under the Anti-Kickback Statute, and Civil Monetary Penalty Rules Regarding Beneficiary Inducements (84 FR 55694). S. 2543, the Prescription Drug Pricing Reduction Act of 2019, sec. 102; and S. 3129/H.R. 19, the Lower Costs, More Cures Act of 2019. Implementation of the Public Health and Social Services Emergency Fund in H.R. 748.
Removing Barriers to Colorectal Cancer Screening Act of 2020
Client: DIGESTIVE HEALTH PHYSICIANS ASSOCIATION, INC. · Firm: THE MCMANUS GROUP
H.R. 1570 / S. 668 - Removing Barriers to Colorectal Cancer Screening Act of 2019. Opposition to H.R. 2143 - Promoting Integrity in Medicare Act of 2019. Support for H.R. 2282 / S. 966 Medicare Care Coordination Improvement Act of 2019. Opposition to step therapy requirement in Medicare Advantage. Support of proposed rules, Medicare Program; Modernizing and Clarifying the Physician Self-Referral Regulations (84 FR 55766) and Medicare and State Healthcare Programs: Fraud and Abuse; Revisions to Safe Harbors Under the Anti-Kickback Statute, and Civil Monetary Penalty Rules Regarding Beneficiary Inducements (84 FR 55694). S. 2543, the Prescription Drug Pricing Reduction Act of 2019, sec. 102; and S. 3129/H.R. 19, the Lower Costs, More Cures Act of 2019. The Public Health and Social Services Emergency Fund in H.R. 748, the CARES Act.
Lower Costs, More Cures Act of 2019
Client: DIGESTIVE HEALTH PHYSICIANS ASSOCIATION, INC. · Firm: THE MCMANUS GROUP
H.R. 1570 / S. 668 - Removing Barriers to Colorectal Cancer Screening Act of 2019. Opposition to H.R. 2143 - Promoting Integrity in Medicare Act of 2019. Support for H.R. 2282 / S. 966 Medicare Care Coordination Improvement Act of 2019. Opposition to step therapy requirement in Medicare Advantage. Support of proposed rules, Medicare Program; Modernizing and Clarifying the Physician Self-Referral Regulations (84 FR 55766) and Medicare and State Healthcare Programs: Fraud and Abuse; Revisions to Safe Harbors Under the Anti-Kickback Statute, and Civil Monetary Penalty Rules Regarding Beneficiary Inducements (84 FR 55694). S. 2543, the Prescription Drug Pricing Reduction Act of 2019, sec. 102; and S. 3129/H.R. 19, the Lower Costs, More Cures Act of 2019. The Public Health and Social Services Emergency Fund in H.R. 748, the CARES Act.
Lower Costs, More Cures Act of 2019
Client: DENDREON PHARMACEUTICALS LLC · Firm: THE MCMANUS GROUP
Medicare Part B payment reform. S. 2543, the Prescription Drug Pricing Reduction Act of 2019 and S. 3129/H.R. 19, the Lower Costs, More Cures Act of 2019. H.R. 748, the CARES Act.
Lower Costs, More Cures Act of 2019
Client: DIGESTIVE HEALTH PHYSICIANS ASSOCIATION, INC. · Firm: THE MCMANUS GROUP
H.R. 1570 / S. 668 - Removing Barriers to Colorectal Cancer Screening Act of 2019. Opposition to H.R. 2143 - Promoting Integrity in Medicare Act of 2019. Support for H.R. 2282 / S. 966 Medicare Care Coordination Improvement Act of 2019. Opposition to step therapy requirement in Medicare Advantage. Support of proposed rules, Medicare Program; Modernizing and Clarifying the Physician Self-Referral Regulations (84 FR 55766) and Medicare and State Healthcare Programs: Fraud and Abuse; Revisions to Safe Harbors Under the Anti-Kickback Statute, and Civil Monetary Penalty Rules Regarding Beneficiary Inducements (84 FR 55694). S. 2543, the Prescription Drug Pricing Reduction Act of 2019, sec. 102; and S. 3129/H.R. 19, the Lower Costs, More Cures Act of 2019. The Public Health and Social Services Emergency Fund in H.R. 748, the CARES Act, and S. 3559/H.R. 6365, the Immediate Relief for Rural Facilities and Providers Act.
Lower Costs, More Cures Act of 2019
Client: DIGESTIVE HEALTH PHYSICIANS ASSOCIATION, INC. · Firm: THE MCMANUS GROUP
H.R. 1570 / S. 668 - Removing Barriers to Colorectal Cancer Screening Act of 2019. Opposition to H.R. 2143 - Promoting Integrity in Medicare Act of 2019. Support for H.R. 2282 / S. 966 Medicare Care Coordination Improvement Act of 2019. Opposition to step therapy requirement in Medicare Advantage. Support of proposed rules, Medicare Program; Modernizing and Clarifying the Physician Self-Referral Regulations (84 FR 55766) and Medicare and State Healthcare Programs: Fraud and Abuse; Revisions to Safe Harbors Under the Anti-Kickback Statute, and Civil Monetary Penalty Rules Regarding Beneficiary Inducements (84 FR 55694). S. 2543, the Prescription Drug Pricing Reduction Act of 2019, sec. 102; and S. 3129/H.R. 19, the Lower Costs, More Cures Act of 2019. Implementation of the Public Health and Social Services Emergency Fund in H.R. 748.
Lower Costs, More Cures Act of 2019
Client: DENDREON PHARMACEUTICALS LLC · Firm: THE MCMANUS GROUP
Medicare Part B payment reform. S. 2543, the Prescription Drug Pricing Reduction Act of 2019 and S. 3129/H.R. 19, the Lower Costs, More Cures Act of 2019. H.R. 748, the CARES Act. Coronavirus relief waivers.
Lower Costs, More Cures Act of 2019
Client: DENDREON PHARMACEUTICALS LLC · Firm: THE MCMANUS GROUP
Medicare Part B payment reform. S. 2543, the Prescription Drug Pricing Reduction Act of 2019 and S. 3129/H.R. 19, the Lower Costs, More Cures Act of 2019. H.R. 748, the CARES Act.
Lower Costs, More Cures Act of 2019
Client: DENDREON PHARMACEUTICALS LLC · Firm: THE MCMANUS GROUP
Medicare Part B payment reform. S. 2543, the Prescription Drug Pricing Reduction Act of 2019 and S. 3129/H.R. 19, the Lower Costs, More Cures Act of 2019. H.R. 748, the CARES Act. Coronavirus relief waivers.
Lower Costs, More Cures Act of 2019
Client: DIGESTIVE HEALTH PHYSICIANS ASSOCIATION, INC. · Firm: THE MCMANUS GROUP
H.R. 1570 / S. 668 - Removing Barriers to Colorectal Cancer Screening Act of 2019. Opposition to H.R. 2143 - Promoting Integrity in Medicare Act of 2019. Support for H.R. 2282 / S. 966 Medicare Care Coordination Improvement Act of 2019. Opposition to step therapy requirement in Medicare Advantage. Support of proposed rules, Medicare Program; Modernizing and Clarifying the Physician Self-Referral Regulations (84 FR 55766) and Medicare and State Healthcare Programs: Fraud and Abuse; Revisions to Safe Harbors Under the Anti-Kickback Statute, and Civil Monetary Penalty Rules Regarding Beneficiary Inducements (84 FR 55694). S. 2543, the Prescription Drug Pricing Reduction Act of 2019, sec. 102; and S. 3129/H.R. 19, the Lower Costs, More Cures Act of 2019. The Public Health and Social Services Emergency Fund in H.R. 748, the CARES Act.
PIMA of 2019
Client: DIGESTIVE HEALTH PHYSICIANS ASSOCIATION, INC. · Firm: THE MCMANUS GROUP
H.R. 1570 / S. 668 - Removing Barriers to Colorectal Cancer Screening Act of 2019. Opposition to H.R. 2143 - Promoting Integrity in Medicare Act of 2019. Support for H.R. 2282 / S. 966 Medicare Care Coordination Improvement Act of 2019. Opposition to step therapy requirement in Medicare Advantage. Support of proposed rules, Medicare Program; Modernizing and Clarifying the Physician Self-Referral Regulations (84 FR 55766) and Medicare and State Healthcare Programs: Fraud and Abuse; Revisions to Safe Harbors Under the Anti-Kickback Statute, and Civil Monetary Penalty Rules Regarding Beneficiary Inducements (84 FR 55694). S. 2543, the Prescription Drug Pricing Reduction Act of 2019, sec. 102; and S. 3129/H.R. 19, the Lower Costs, More Cures Act of 2019. The Public Health and Social Services Emergency Fund in H.R. 748, the CARES Act, and S. 3559/H.R. 6365, the Immediate Relief for Rural Facilities and Providers Act.
PIMA of 2019
Client: DIGESTIVE HEALTH PHYSICIANS ASSOCIATION, INC. · Firm: THE MCMANUS GROUP
H.R. 1570 / S. 668 - Removing Barriers to Colorectal Cancer Screening Act of 2019. Opposition to H.R. 2143 - Promoting Integrity in Medicare Act of 2019. Support for H.R. 2282 / S. 966 Medicare Care Coordination Improvement Act of 2019. Opposition to step therapy requirement in Medicare Advantage. Support of proposed rules, Medicare Program; Modernizing and Clarifying the Physician Self-Referral Regulations (84 FR 55766) and Medicare and State Healthcare Programs: Fraud and Abuse; Revisions to Safe Harbors Under the Anti-Kickback Statute, and Civil Monetary Penalty Rules Regarding Beneficiary Inducements (84 FR 55694). S. 2543, the Prescription Drug Pricing Reduction Act of 2019, sec. 102; and S. 3129/H.R. 19, the Lower Costs, More Cures Act of 2019. Implementation of the Public Health and Social Services Emergency Fund in H.R. 748.
PIMA of 2019
Client: DIGESTIVE HEALTH PHYSICIANS ASSOCIATION, INC. · Firm: THE MCMANUS GROUP
H.R. 1570 / S. 668 - Removing Barriers to Colorectal Cancer Screening Act of 2019. Opposition to H.R. 2143 - Promoting Integrity in Medicare Act of 2019. Support for H.R. 2282 / S. 966 Medicare Care Coordination Improvement Act of 2019. Opposition to step therapy requirement in Medicare Advantage. Support of proposed rules, Medicare Program; Modernizing and Clarifying the Physician Self-Referral Regulations (84 FR 55766) and Medicare and State Healthcare Programs: Fraud and Abuse; Revisions to Safe Harbors Under the Anti-Kickback Statute, and Civil Monetary Penalty Rules Regarding Beneficiary Inducements (84 FR 55694). S. 2543, the Prescription Drug Pricing Reduction Act of 2019, sec. 102; and S. 3129/H.R. 19, the Lower Costs, More Cures Act of 2019. The Public Health and Social Services Emergency Fund in H.R. 748, the CARES Act.
PIMA of 2019
Client: DIGESTIVE HEALTH PHYSICIANS ASSOCIATION, INC. · Firm: THE MCMANUS GROUP
H.R. 1570 / S. 668 - Removing Barriers to Colorectal Cancer Screening Act of 2019. Opposition to H.R. 2143 - Promoting Integrity in Medicare Act of 2019. Support for H.R. 2282 / S. 966 Medicare Care Coordination Improvement Act of 2019. Opposition to step therapy requirement in Medicare Advantage. Support of proposed rules, Medicare Program; Modernizing and Clarifying the Physician Self-Referral Regulations (84 FR 55766) and Medicare and State Healthcare Programs: Fraud and Abuse; Revisions to Safe Harbors Under the Anti-Kickback Statute, and Civil Monetary Penalty Rules Regarding Beneficiary Inducements (84 FR 55694). S. 2543, the Prescription Drug Pricing Reduction Act of 2019, sec. 102; and S. 3129/H.R. 19, the Lower Costs, More Cures Act of 2019. The Public Health and Social Services Emergency Fund in H.R. 748, the CARES Act.
Medicare Care Coordination Improvement Act of 2019
Client: DIGESTIVE HEALTH PHYSICIANS ASSOCIATION, INC. · Firm: THE MCMANUS GROUP
H.R. 1570 / S. 668 - Removing Barriers to Colorectal Cancer Screening Act of 2019. Opposition to H.R. 2143 - Promoting Integrity in Medicare Act of 2019. Support for H.R. 2282 / S. 966 Medicare Care Coordination Improvement Act of 2019. Opposition to step therapy requirement in Medicare Advantage. Support of proposed rules, Medicare Program; Modernizing and Clarifying the Physician Self-Referral Regulations (84 FR 55766) and Medicare and State Healthcare Programs: Fraud and Abuse; Revisions to Safe Harbors Under the Anti-Kickback Statute, and Civil Monetary Penalty Rules Regarding Beneficiary Inducements (84 FR 55694). S. 2543, the Prescription Drug Pricing Reduction Act of 2019, sec. 102; and S. 3129/H.R. 19, the Lower Costs, More Cures Act of 2019. The Public Health and Social Services Emergency Fund in H.R. 748, the CARES Act.
Medicare Care Coordination Improvement Act of 2019
Client: DIGESTIVE HEALTH PHYSICIANS ASSOCIATION, INC. · Firm: THE MCMANUS GROUP
H.R. 1570 / S. 668 - Removing Barriers to Colorectal Cancer Screening Act of 2019. Opposition to H.R. 2143 - Promoting Integrity in Medicare Act of 2019. Support for H.R. 2282 / S. 966 Medicare Care Coordination Improvement Act of 2019. Opposition to step therapy requirement in Medicare Advantage. Support of proposed rules, Medicare Program; Modernizing and Clarifying the Physician Self-Referral Regulations (84 FR 55766) and Medicare and State Healthcare Programs: Fraud and Abuse; Revisions to Safe Harbors Under the Anti-Kickback Statute, and Civil Monetary Penalty Rules Regarding Beneficiary Inducements (84 FR 55694). S. 2543, the Prescription Drug Pricing Reduction Act of 2019, sec. 102; and S. 3129/H.R. 19, the Lower Costs, More Cures Act of 2019. The Public Health and Social Services Emergency Fund in H.R. 748, the CARES Act.
Medicare Care Coordination Improvement Act of 2019
Client: DIGESTIVE HEALTH PHYSICIANS ASSOCIATION, INC. · Firm: THE MCMANUS GROUP
H.R. 1570 / S. 668 - Removing Barriers to Colorectal Cancer Screening Act of 2019. Opposition to H.R. 2143 - Promoting Integrity in Medicare Act of 2019. Support for H.R. 2282 / S. 966 Medicare Care Coordination Improvement Act of 2019. Opposition to step therapy requirement in Medicare Advantage. Support of proposed rules, Medicare Program; Modernizing and Clarifying the Physician Self-Referral Regulations (84 FR 55766) and Medicare and State Healthcare Programs: Fraud and Abuse; Revisions to Safe Harbors Under the Anti-Kickback Statute, and Civil Monetary Penalty Rules Regarding Beneficiary Inducements (84 FR 55694). S. 2543, the Prescription Drug Pricing Reduction Act of 2019, sec. 102; and S. 3129/H.R. 19, the Lower Costs, More Cures Act of 2019. The Public Health and Social Services Emergency Fund in H.R. 748, the CARES Act, and S. 3559/H.R. 6365, the Immediate Relief for Rural Facilities and Providers Act.
Medicare Care Coordination Improvement Act of 2019
Client: DIGESTIVE HEALTH PHYSICIANS ASSOCIATION, INC. · Firm: THE MCMANUS GROUP
H.R. 1570 / S. 668 - Removing Barriers to Colorectal Cancer Screening Act of 2019. Opposition to H.R. 2143 - Promoting Integrity in Medicare Act of 2019. Support for H.R. 2282 / S. 966 Medicare Care Coordination Improvement Act of 2019. Opposition to step therapy requirement in Medicare Advantage. Support of proposed rules, Medicare Program; Modernizing and Clarifying the Physician Self-Referral Regulations (84 FR 55766) and Medicare and State Healthcare Programs: Fraud and Abuse; Revisions to Safe Harbors Under the Anti-Kickback Statute, and Civil Monetary Penalty Rules Regarding Beneficiary Inducements (84 FR 55694). S. 2543, the Prescription Drug Pricing Reduction Act of 2019, sec. 102; and S. 3129/H.R. 19, the Lower Costs, More Cures Act of 2019. Implementation of the Public Health and Social Services Emergency Fund in H.R. 748.
Medicare Home Health Flexibility Act
Client: AMERICAN OCCUPATIONAL THERAPY ASSOCIATION · Firm: THE MCMANUS GROUP
Support for reform of OT opening cases in home health. H.R. 3127/S. 1725, the Medicare Home Health Flexibility Act. Implementation of Physician Fee Schedule in 84 FR 62568. The Public Health and Social Services Emergency Fund provision in H.R. 748, the CARES Act.
Medicare Home Health Flexibility Act
Client: AMERICAN OCCUPATIONAL THERAPY ASSOCIATION · Firm: THE MCMANUS GROUP
Support for reform of OT opening cases in home health. H.R. 3127/S. 1725, the Medicare Home Health Flexibility Act. Implementation of Physician Fee Schedule in 84 FR 62568. Implementation of the Public Health and Social Services Emergency Fund provision in H.R. 748. Medicare telehealth expansion in CMS-1744-IFC and CMS-5531-IFC
HEARTS and Rural Relief Act
Client: AMBULATORY SURGERY CENTER ASSOCIATION · Firm: THE MCMANUS GROUP
Support for H.R.4350/S. 3085, The Ambulatory Surgical Center Quality and Access Act of 2019, and legislation to tie ambulatory surgery center payment updates to the hospital market basket. H.R. 3429, the HEARTS and Rural Relief Act of 2019. Increase patient access to procedures in ASCs. Implementation of the Public Health and Social Services Emergency Fund provision in H.R. 748. Discontinuance of ASC relative weight scalar.
HEARTS and Rural Relief Act
Client: AMBULATORY SURGERY CENTER ASSOCIATION · Firm: THE MCMANUS GROUP
Support for H.R.4350/S. 3085, The Ambulatory Surgical Center Quality and Access Act of 2019, and legislation to tie ambulatory surgery center payment updates to the hospital market basket. H.R. 3429, the HEARTS and Rural Relief Act of 2019. Increase patient access to procedures in ASCs. The Public Health and Social Services Emergency Fund provision in H.R. 748, the CARES Act, as well as S. 3559/ H.R. 6365, The Immediate Relief for Rural Facilities and Providers Act of 2020.
HEARTS and Rural Relief Act
Client: AMBULATORY SURGERY CENTER ASSOCIATION · Firm: THE MCMANUS GROUP
Support for H.R.4350/S. 3085, The Ambulatory Surgical Center Quality and Access Act of 2019, and legislation to tie ambulatory surgery center payment updates to the hospital market basket. H.R. 3429, the HEARTS and Rural Relief Act of 2019. Increase patient access to procedures in ASCs. The Public Health and Social Services Emergency Fund provision in H.R. 748, the CARES Act.
No Surprises Act
Client: NATIONAL ASSOCIATION OF FREESTANDING EMERGENCY CENTERS (NAFEC) · Firm: THE MCMANUS GROUP
Surprise billing reform, including S. 1895, the Lower Health Care Costs Act, H.R. 3630, the No Surprises Act, H.R. 5826, the Consumer Protections Against Surprise Medical Bills Act, and H.R. 5800, the Ban Surprise Bills Act.
No Surprises Act
Client: NATIONAL ASSOCIATION OF FREESTANDING EMERGENCY CENTERS (NAFEC) · Firm: THE MCMANUS GROUP
Surprise billing reform, including S. 1895, the Lower Health Care Costs Act, H.R. 3630, the No Surprises Act, H.R. 5826, the Consumer Protections Against Surprise Medical Bills Act, and H.R. 5800, the Ban Surprise Bills Act.
No Surprises Act
Client: NATIONAL ASSOCIATION OF FREESTANDING EMERGENCY CENTERS (NAFEC) · Firm: THE MCMANUS GROUP
Requirements related to COVID-19 testing. Surprise billing reform, including S. 1895, the Lower Health Care Costs Act, H.R. 3630, the No Surprises Act, H.R. 5826, the Consumer Protections Against Surprise Medical Bills Act, and H.R. 5800, the Ban Surprise Bills Act.
No Surprises Act
Client: NATIONAL ASSOCIATION OF FREESTANDING EMERGENCY CENTERS (NAFEC) · Firm: THE MCMANUS GROUP
Requirements related to COVID-19 testing. Surprise billing reform, including S. 1895, the Lower Health Care Costs Act, H.R. 3630, the No Surprises Act, H.R. 5826, the Consumer Protections Against Surprise Medical Bills Act, and H.R. 5800, the Ban Surprise Bills Act.
No Surprises Act
Client: NATIONAL ASSOCIATION OF FREESTANDING EMERGENCY CENTERS (NAFEC) · Firm: THE MCMANUS GROUP
Requirements related to COVID-19 testing. Surprise billing reform, including S. 1895, the Lower Health Care Costs Act, H.R. 3630, the No Surprises Act, H.R. 5826, the Consumer Protections Against Surprise Medical Bills Act, and H.R. 5800, the Ban Surprise Bills Act.
Ambulatory Surgical Center Quality and Access Act of 2019
Client: AMBULATORY SURGERY CENTER ASSOCIATION · Firm: THE MCMANUS GROUP
Support for H.R.4350/S. 3085, The Ambulatory Surgical Center Quality and Access Act of 2019, and legislation to tie ambulatory surgery center payment updates to the hospital market basket. H.R. 3429, the HEARTS and Rural Relief Act of 2019. Increase patient access to procedures in ASCs. The Public Health and Social Services Emergency Fund provision in H.R. 748, the CARES Act.
Ambulatory Surgical Center Quality and Access Act of 2019
Client: AMBULATORY SURGERY CENTER ASSOCIATION · Firm: THE MCMANUS GROUP
Support for H.R.4350/S. 3085, The Ambulatory Surgical Center Quality and Access Act of 2019, and legislation to tie ambulatory surgery center payment updates to the hospital market basket. H.R. 3429, the HEARTS and Rural Relief Act of 2019. Increase patient access to procedures in ASCs. Implementation of the Public Health and Social Services Emergency Fund provision in H.R. 748. Discontinuance of ASC relative weight scalar.
Ambulatory Surgical Center Quality and Access Act of 2019
Client: AMBULATORY SURGERY CENTER ASSOCIATION · Firm: THE MCMANUS GROUP
Support for H.R.4350/S. 3085, The Ambulatory Surgical Center Quality and Access Act of 2019, and legislation to tie ambulatory surgery center payment updates to the hospital market basket. H.R. 3429, the HEARTS and Rural Relief Act of 2019. Increase patient access to procedures in ASCs. The Public Health and Social Services Emergency Fund provision in H.R. 748, the CARES Act, as well as S. 3559/ H.R. 6365, The Immediate Relief for Rural Facilities and Providers Act of 2020.
Ban Surprise Billing Act
Client: NATIONAL ASSOCIATION OF FREESTANDING EMERGENCY CENTERS (NAFEC) · Firm: THE MCMANUS GROUP
Surprise billing reform, including S. 1895, the Lower Health Care Costs Act, H.R. 3630, the No Surprises Act, H.R. 5826, the Consumer Protections Against Surprise Medical Bills Act, and H.R. 5800, the Ban Surprise Bills Act.
Ban Surprise Billing Act
Client: NATIONAL ASSOCIATION OF FREESTANDING EMERGENCY CENTERS (NAFEC) · Firm: THE MCMANUS GROUP
Surprise billing reform, including S. 1895, the Lower Health Care Costs Act, H.R. 3630, the No Surprises Act, H.R. 5826, the Consumer Protections Against Surprise Medical Bills Act, and H.R. 5800, the Ban Surprise Bills Act.
Ban Surprise Billing Act
Client: NATIONAL ASSOCIATION OF FREESTANDING EMERGENCY CENTERS (NAFEC) · Firm: THE MCMANUS GROUP
Requirements related to COVID-19 testing. Surprise billing reform, including S. 1895, the Lower Health Care Costs Act, H.R. 3630, the No Surprises Act, H.R. 5826, the Consumer Protections Against Surprise Medical Bills Act, and H.R. 5800, the Ban Surprise Bills Act.
Ban Surprise Billing Act
Client: NATIONAL ASSOCIATION OF FREESTANDING EMERGENCY CENTERS (NAFEC) · Firm: THE MCMANUS GROUP
Requirements related to COVID-19 testing. Surprise billing reform, including S. 1895, the Lower Health Care Costs Act, H.R. 3630, the No Surprises Act, H.R. 5826, the Consumer Protections Against Surprise Medical Bills Act, and H.R. 5800, the Ban Surprise Bills Act.
Ban Surprise Billing Act
Client: NATIONAL ASSOCIATION OF FREESTANDING EMERGENCY CENTERS (NAFEC) · Firm: THE MCMANUS GROUP
Requirements related to COVID-19 testing. Surprise billing reform, including S. 1895, the Lower Health Care Costs Act, H.R. 3630, the No Surprises Act, H.R. 5826, the Consumer Protections Against Surprise Medical Bills Act, and H.R. 5800, the Ban Surprise Bills Act.
Consumer Protections Against Surprise Medical Bills Act of 2020
Client: NATIONAL ASSOCIATION OF FREESTANDING EMERGENCY CENTERS (NAFEC) · Firm: THE MCMANUS GROUP
Requirements related to COVID-19 testing. Surprise billing reform, including S. 1895, the Lower Health Care Costs Act, H.R. 3630, the No Surprises Act, H.R. 5826, the Consumer Protections Against Surprise Medical Bills Act, and H.R. 5800, the Ban Surprise Bills Act.
Consumer Protections Against Surprise Medical Bills Act of 2020
Client: NATIONAL ASSOCIATION OF FREESTANDING EMERGENCY CENTERS (NAFEC) · Firm: THE MCMANUS GROUP
Requirements related to COVID-19 testing. Surprise billing reform, including S. 1895, the Lower Health Care Costs Act, H.R. 3630, the No Surprises Act, H.R. 5826, the Consumer Protections Against Surprise Medical Bills Act, and H.R. 5800, the Ban Surprise Bills Act.
Consumer Protections Against Surprise Medical Bills Act of 2020
Client: NATIONAL ASSOCIATION OF FREESTANDING EMERGENCY CENTERS (NAFEC) · Firm: THE MCMANUS GROUP
Surprise billing reform, including S. 1895, the Lower Health Care Costs Act, H.R. 3630, the No Surprises Act, H.R. 5826, the Consumer Protections Against Surprise Medical Bills Act, and H.R. 5800, the Ban Surprise Bills Act.
Consumer Protections Against Surprise Medical Bills Act of 2020
Client: NATIONAL ASSOCIATION OF FREESTANDING EMERGENCY CENTERS (NAFEC) · Firm: THE MCMANUS GROUP
Surprise billing reform, including S. 1895, the Lower Health Care Costs Act, H.R. 3630, the No Surprises Act, H.R. 5826, the Consumer Protections Against Surprise Medical Bills Act, and H.R. 5800, the Ban Surprise Bills Act.
Consumer Protections Against Surprise Medical Bills Act of 2020
Client: NATIONAL ASSOCIATION OF FREESTANDING EMERGENCY CENTERS (NAFEC) · Firm: THE MCMANUS GROUP
Requirements related to COVID-19 testing. Surprise billing reform, including S. 1895, the Lower Health Care Costs Act, H.R. 3630, the No Surprises Act, H.R. 5826, the Consumer Protections Against Surprise Medical Bills Act, and H.R. 5800, the Ban Surprise Bills Act.
Immediate Relief for Rural Facilities and Providers Act of 2020
Client: AMBULATORY SURGERY CENTER ASSOCIATION · Firm: THE MCMANUS GROUP
Support for H.R.4350/S. 3085, The Ambulatory Surgical Center Quality and Access Act of 2019, and legislation to tie ambulatory surgery center payment updates to the hospital market basket. H.R. 3429, the HEARTS and Rural Relief Act of 2019. Increase patient access to procedures in ASCs. The Public Health and Social Services Emergency Fund provision in H.R. 748, the CARES Act, as well as S. 3559/ H.R. 6365, The Immediate Relief for Rural Facilities and Providers Act of 2020.
Immediate Relief for Rural Facilities and Providers Act of 2020
Client: AMBULATORY SURGERY CENTER ASSOCIATION · Firm: THE MCMANUS GROUP
S. 3559/ H.R. 6365, The Immediate Relief for Rural Facilities and Providers Act of 2020.
Immediate Relief for Rural Facilities and Providers Act of 2020
Client: DIGESTIVE HEALTH PHYSICIANS ASSOCIATION, INC. · Firm: THE MCMANUS GROUP
H.R. 1570 / S. 668 - Removing Barriers to Colorectal Cancer Screening Act of 2019. Opposition to H.R. 2143 - Promoting Integrity in Medicare Act of 2019. Support for H.R. 2282 / S. 966 Medicare Care Coordination Improvement Act of 2019. Opposition to step therapy requirement in Medicare Advantage. Support of proposed rules, Medicare Program; Modernizing and Clarifying the Physician Self-Referral Regulations (84 FR 55766) and Medicare and State Healthcare Programs: Fraud and Abuse; Revisions to Safe Harbors Under the Anti-Kickback Statute, and Civil Monetary Penalty Rules Regarding Beneficiary Inducements (84 FR 55694). S. 2543, the Prescription Drug Pricing Reduction Act of 2019, sec. 102; and S. 3129/H.R. 19, the Lower Costs, More Cures Act of 2019. The Public Health and Social Services Emergency Fund in H.R. 748, the CARES Act, and S. 3559/H.R. 6365, the Immediate Relief for Rural Facilities and Providers Act.
Immediate Relief for Rural Facilities and Providers Act of 2020
Client: AMBULATORY SURGERY CENTER ASSOCIATION · Firm: THE MCMANUS GROUP
S. 3559/ H.R. 6365, The Immediate Relief for Rural Facilities and Providers Act of 2020.
Paycheck Protection Program Flexibility Act of 2020
Client: AMBULATORY SURGERY CENTER ASSOCIATION · Firm: THE MCMANUS GROUP
Implementation of the Paycheck Protection Program and H.R. 7010/ S. 38015, the Paycheck Protection Program Flexibility Act.
S. 12 - Health Savings Act of 2019. Inclusion of COBRA provision in H.R. 748, the CARES Act.
Medicare Part B payment reform. S. 2543, the Prescription Drug Pricing Reduction Act of 2019 and S. 3129/H.R. 19, the Lower Costs, More Cures Act of 2019. H.R. 748, the CARES Act. Coronavirus relief waivers.
H.R. 1570 / S. 668 - Removing Barriers to Colorectal Cancer Screening Act of 2019. Opposition to H.R. 2143 - Promoting Integrity in Medicare Act of 2019. Support for H.R. 2282 / S. 966 Medicare Care Coordination Improvement Act of 2019. Opposition to step therapy requirement in Medicare Advantage. Support of proposed rules, Medicare Program; Modernizing and Clarifying the Physician Self-Referral Regulations (84 FR 55766) and Medicare and State Healthcare Programs: Fraud and Abuse; Revisions to Safe Harbors Under the Anti-Kickback Statute, and Civil Monetary Penalty Rules Regarding Beneficiary Inducements (84 FR 55694). S. 2543, the Prescription Drug Pricing Reduction Act of 2019, sec. 102; and S. 3129/H.R. 19, the Lower Costs, More Cures Act of 2019. The Public Health and Social Services Emergency Fund in H.R. 748, the CARES Act.
Support for H.R.4350/S. 3085, The Ambulatory Surgical Center Quality and Access Act of 2019, and legislation to tie ambulatory surgery center payment updates to the hospital market basket. H.R. 3429, the HEARTS and Rural Relief Act of 2019. Increase patient access to procedures in ASCs. Implementation of the Public Health and Social Services Emergency Fund provision in H.R. 748. Discontinuance of ASC relative weight scalar.
The Paycheck Protection Program in H.R. 748, the CARES Act.
H.R. 1570 / S. 668 - Removing Barriers to Colorectal Cancer Screening Act of 2019. Opposition to H.R. 2143 - Promoting Integrity in Medicare Act of 2019. Support for H.R. 2282 / S. 966 Medicare Care Coordination Improvement Act of 2019. Opposition to step therapy requirement in Medicare Advantage. Support of proposed rules, Medicare Program; Modernizing and Clarifying the Physician Self-Referral Regulations (84 FR 55766) and Medicare and State Healthcare Programs: Fraud and Abuse; Revisions to Safe Harbors Under the Anti-Kickback Statute, and Civil Monetary Penalty Rules Regarding Beneficiary Inducements (84 FR 55694). S. 2543, the Prescription Drug Pricing Reduction Act of 2019, sec. 102; and S. 3129/H.R. 19, the Lower Costs, More Cures Act of 2019. The Public Health and Social Services Emergency Fund in H.R. 748, the CARES Act, and S. 3559/H.R. 6365, the Immediate Relief for Rural Facilities and Providers Act.
Support for reform of OT opening cases in home health. H.R. 3127/S. 1725, the Medicare Home Health Flexibility Act. Implementation of Physician Fee Schedule in 84 FR 62568. Implementation of the Public Health and Social Services Emergency Fund provision in H.R. 748. Medicare telehealth expansion in CMS-1744-IFC and CMS-5531-IFC
Support for H.R.4350/S. 3085, The Ambulatory Surgical Center Quality and Access Act of 2019, and legislation to tie ambulatory surgery center payment updates to the hospital market basket. H.R. 3429, the HEARTS and Rural Relief Act of 2019. Increase patient access to procedures in ASCs. The Public Health and Social Services Emergency Fund provision in H.R. 748, the CARES Act.
Support for reform of OT opening cases in home health. H.R. 3127/S. 1725, the Medicare Home Health Flexibility Act. Implementation of Physician Fee Schedule in 84 FR 62568. The Public Health and Social Services Emergency Fund provision in H.R. 748, the CARES Act.
Medicare Part B payment reform. S. 2543, the Prescription Drug Pricing Reduction Act of 2019 and S. 3129/H.R. 19, the Lower Costs, More Cures Act of 2019. H.R. 748, the CARES Act.
CARES Act
Client: NATIONAL ASSOCIATION OF FREESTANDING EMERGENCY CENTERS (NAFEC) · Firm: THE MCMANUS GROUP
Education and advocacy regarding emergency services and Medicare reimbursement of freestanding emergency centers, including H.R. 748, the CARES Act, and CMS-1744-IFC.
Support for H.R.4350/S. 3085, The Ambulatory Surgical Center Quality and Access Act of 2019, and legislation to tie ambulatory surgery center payment updates to the hospital market basket. H.R. 3429, the HEARTS and Rural Relief Act of 2019. Increase patient access to procedures in ASCs. The Public Health and Social Services Emergency Fund provision in H.R. 748, the CARES Act, as well as S. 3559/ H.R. 6365, The Immediate Relief for Rural Facilities and Providers Act of 2020.
The Paycheck Protection Program in H.R. 748, the CARES Act.
H.R. 1570 / S. 668 - Removing Barriers to Colorectal Cancer Screening Act of 2019. Opposition to H.R. 2143 - Promoting Integrity in Medicare Act of 2019. Support for H.R. 2282 / S. 966 Medicare Care Coordination Improvement Act of 2019. Opposition to step therapy requirement in Medicare Advantage. Support of proposed rules, Medicare Program; Modernizing and Clarifying the Physician Self-Referral Regulations (84 FR 55766) and Medicare and State Healthcare Programs: Fraud and Abuse; Revisions to Safe Harbors Under the Anti-Kickback Statute, and Civil Monetary Penalty Rules Regarding Beneficiary Inducements (84 FR 55694). S. 2543, the Prescription Drug Pricing Reduction Act of 2019, sec. 102; and S. 3129/H.R. 19, the Lower Costs, More Cures Act of 2019. The Public Health and Social Services Emergency Fund in H.R. 748, the CARES Act.
H.R. 1570 / S. 668 - Removing Barriers to Colorectal Cancer Screening Act of 2019. Opposition to H.R. 2143 - Promoting Integrity in Medicare Act of 2019. Support for H.R. 2282 / S. 966 Medicare Care Coordination Improvement Act of 2019. Opposition to step therapy requirement in Medicare Advantage. Support of proposed rules, Medicare Program; Modernizing and Clarifying the Physician Self-Referral Regulations (84 FR 55766) and Medicare and State Healthcare Programs: Fraud and Abuse; Revisions to Safe Harbors Under the Anti-Kickback Statute, and Civil Monetary Penalty Rules Regarding Beneficiary Inducements (84 FR 55694). S. 2543, the Prescription Drug Pricing Reduction Act of 2019, sec. 102; and S. 3129/H.R. 19, the Lower Costs, More Cures Act of 2019. Implementation of the Public Health and Social Services Emergency Fund in H.R. 748.
Medicare Part B payment reform. S. 2543, the Prescription Drug Pricing Reduction Act of 2019 and S. 3129/H.R. 19, the Lower Costs, More Cures Act of 2019. H.R. 748, the CARES Act.
The Paycheck Protection Program in H.R. 748, the CARES Act.
Medicare Part B payment reform. S. 2543, the Prescription Drug Pricing Reduction Act of 2019 and S. 3129/H.R. 19, the Lower Costs, More Cures Act of 2019. H.R. 748, the CARES Act. Coronavirus relief waivers.
S. 12 - Health Savings Act of 2019. Inclusion of COBRA provision in H.R. 748, the CARES Act.
S. 12 - Health Savings Act of 2019. Inclusion of COBRA provision in coronavirus relief legislation. Issues related to to Pandemic Health Accounts.
Medicare Home Health Flexibility Act of 2019
Client: AMERICAN OCCUPATIONAL THERAPY ASSOCIATION · Firm: THE MCMANUS GROUP
Support for reform of OT opening cases in home health. H.R. 3127/S. 1725, the Medicare Home Health Flexibility Act. Implementation of Physician Fee Schedule in 84 FR 62568. The Public Health and Social Services Emergency Fund provision in H.R. 748, the CARES Act.
Medicare Home Health Flexibility Act of 2019
Client: AMERICAN OCCUPATIONAL THERAPY ASSOCIATION · Firm: THE MCMANUS GROUP
Support for reform of OT opening cases in home health. H.R. 3127/S. 1725, the Medicare Home Health Flexibility Act. Implementation of Physician Fee Schedule in 84 FR 62568. Implementation of the Public Health and Social Services Emergency Fund provision in H.R. 748. Medicare telehealth expansion in CMS-1744-IFC and CMS-5531-IFC
Lower Health Care Costs Act
Client: NATIONAL ASSOCIATION OF FREESTANDING EMERGENCY CENTERS (NAFEC) · Firm: THE MCMANUS GROUP
Surprise billing reform, including S. 1895, the Lower Health Care Costs Act, H.R. 3630, the No Surprises Act, H.R. 5826, the Consumer Protections Against Surprise Medical Bills Act, and H.R. 5800, the Ban Surprise Bills Act.
Lower Health Care Costs Act
Client: NATIONAL ASSOCIATION OF FREESTANDING EMERGENCY CENTERS (NAFEC) · Firm: THE MCMANUS GROUP
Requirements related to COVID-19 testing. Surprise billing reform, including S. 1895, the Lower Health Care Costs Act, H.R. 3630, the No Surprises Act, H.R. 5826, the Consumer Protections Against Surprise Medical Bills Act, and H.R. 5800, the Ban Surprise Bills Act.
Lower Health Care Costs Act
Client: NATIONAL ASSOCIATION OF FREESTANDING EMERGENCY CENTERS (NAFEC) · Firm: THE MCMANUS GROUP
Surprise billing reform, including S. 1895, the Lower Health Care Costs Act, H.R. 3630, the No Surprises Act, H.R. 5826, the Consumer Protections Against Surprise Medical Bills Act, and H.R. 5800, the Ban Surprise Bills Act.
Lower Health Care Costs Act
Client: NATIONAL ASSOCIATION OF FREESTANDING EMERGENCY CENTERS (NAFEC) · Firm: THE MCMANUS GROUP
Requirements related to COVID-19 testing. Surprise billing reform, including S. 1895, the Lower Health Care Costs Act, H.R. 3630, the No Surprises Act, H.R. 5826, the Consumer Protections Against Surprise Medical Bills Act, and H.R. 5800, the Ban Surprise Bills Act.
Lower Health Care Costs Act
Client: NATIONAL ASSOCIATION OF FREESTANDING EMERGENCY CENTERS (NAFEC) · Firm: THE MCMANUS GROUP
Requirements related to COVID-19 testing. Surprise billing reform, including S. 1895, the Lower Health Care Costs Act, H.R. 3630, the No Surprises Act, H.R. 5826, the Consumer Protections Against Surprise Medical Bills Act, and H.R. 5800, the Ban Surprise Bills Act.
Prescription Drug Pricing Reduction Act of 2019
Client: DENDREON PHARMACEUTICALS LLC · Firm: THE MCMANUS GROUP
Medicare Part B payment reform. S. 2543, the Prescription Drug Pricing Reduction Act of 2019 and S. 3129/H.R. 19, the Lower Costs, More Cures Act of 2019. H.R. 748, the CARES Act. Coronavirus relief waivers.
Prescription Drug Pricing Reduction Act of 2019
Client: DIGESTIVE HEALTH PHYSICIANS ASSOCIATION, INC. · Firm: THE MCMANUS GROUP
H.R. 1570 / S. 668 - Removing Barriers to Colorectal Cancer Screening Act of 2019. Opposition to H.R. 2143 - Promoting Integrity in Medicare Act of 2019. Support for H.R. 2282 / S. 966 Medicare Care Coordination Improvement Act of 2019. Opposition to step therapy requirement in Medicare Advantage. Support of proposed rules, Medicare Program; Modernizing and Clarifying the Physician Self-Referral Regulations (84 FR 55766) and Medicare and State Healthcare Programs: Fraud and Abuse; Revisions to Safe Harbors Under the Anti-Kickback Statute, and Civil Monetary Penalty Rules Regarding Beneficiary Inducements (84 FR 55694). S. 2543, the Prescription Drug Pricing Reduction Act of 2019, sec. 102; and S. 3129/H.R. 19, the Lower Costs, More Cures Act of 2019. The Public Health and Social Services Emergency Fund in H.R. 748, the CARES Act.
Prescription Drug Pricing Reduction Act of 2019
Client: DENDREON PHARMACEUTICALS LLC · Firm: THE MCMANUS GROUP
Medicare Part B payment reform. S. 2543, the Prescription Drug Pricing Reduction Act of 2019 and S. 3129/H.R. 19, the Lower Costs, More Cures Act of 2019. H.R. 748, the CARES Act.
Prescription Drug Pricing Reduction Act of 2019
Client: DENDREON PHARMACEUTICALS LLC · Firm: THE MCMANUS GROUP
Medicare Part B payment reform. S. 2543, the Prescription Drug Pricing Reduction Act of 2019 and S. 3129/H.R. 19, the Lower Costs, More Cures Act of 2019. H.R. 748, the CARES Act.
Prescription Drug Pricing Reduction Act of 2019
Client: DIGESTIVE HEALTH PHYSICIANS ASSOCIATION, INC. · Firm: THE MCMANUS GROUP
H.R. 1570 / S. 668 - Removing Barriers to Colorectal Cancer Screening Act of 2019. Opposition to H.R. 2143 - Promoting Integrity in Medicare Act of 2019. Support for H.R. 2282 / S. 966 Medicare Care Coordination Improvement Act of 2019. Opposition to step therapy requirement in Medicare Advantage. Support of proposed rules, Medicare Program; Modernizing and Clarifying the Physician Self-Referral Regulations (84 FR 55766) and Medicare and State Healthcare Programs: Fraud and Abuse; Revisions to Safe Harbors Under the Anti-Kickback Statute, and Civil Monetary Penalty Rules Regarding Beneficiary Inducements (84 FR 55694). S. 2543, the Prescription Drug Pricing Reduction Act of 2019, sec. 102; and S. 3129/H.R. 19, the Lower Costs, More Cures Act of 2019. Implementation of the Public Health and Social Services Emergency Fund in H.R. 748.
Prescription Drug Pricing Reduction Act of 2019
Client: DIGESTIVE HEALTH PHYSICIANS ASSOCIATION, INC. · Firm: THE MCMANUS GROUP
H.R. 1570 / S. 668 - Removing Barriers to Colorectal Cancer Screening Act of 2019. Opposition to H.R. 2143 - Promoting Integrity in Medicare Act of 2019. Support for H.R. 2282 / S. 966 Medicare Care Coordination Improvement Act of 2019. Opposition to step therapy requirement in Medicare Advantage. Support of proposed rules, Medicare Program; Modernizing and Clarifying the Physician Self-Referral Regulations (84 FR 55766) and Medicare and State Healthcare Programs: Fraud and Abuse; Revisions to Safe Harbors Under the Anti-Kickback Statute, and Civil Monetary Penalty Rules Regarding Beneficiary Inducements (84 FR 55694). S. 2543, the Prescription Drug Pricing Reduction Act of 2019, sec. 102; and S. 3129/H.R. 19, the Lower Costs, More Cures Act of 2019. The Public Health and Social Services Emergency Fund in H.R. 748, the CARES Act, and S. 3559/H.R. 6365, the Immediate Relief for Rural Facilities and Providers Act.
Prescription Drug Pricing Reduction Act of 2019
Client: DENDREON PHARMACEUTICALS LLC · Firm: THE MCMANUS GROUP
Medicare Part B payment reform. S. 2543, the Prescription Drug Pricing Reduction Act of 2019 and S. 3129/H.R. 19, the Lower Costs, More Cures Act of 2019. H.R. 748, the CARES Act. Coronavirus relief waivers.
Prescription Drug Pricing Reduction Act of 2019
Client: DIGESTIVE HEALTH PHYSICIANS ASSOCIATION, INC. · Firm: THE MCMANUS GROUP
H.R. 1570 / S. 668 - Removing Barriers to Colorectal Cancer Screening Act of 2019. Opposition to H.R. 2143 - Promoting Integrity in Medicare Act of 2019. Support for H.R. 2282 / S. 966 Medicare Care Coordination Improvement Act of 2019. Opposition to step therapy requirement in Medicare Advantage. Support of proposed rules, Medicare Program; Modernizing and Clarifying the Physician Self-Referral Regulations (84 FR 55766) and Medicare and State Healthcare Programs: Fraud and Abuse; Revisions to Safe Harbors Under the Anti-Kickback Statute, and Civil Monetary Penalty Rules Regarding Beneficiary Inducements (84 FR 55694). S. 2543, the Prescription Drug Pricing Reduction Act of 2019, sec. 102; and S. 3129/H.R. 19, the Lower Costs, More Cures Act of 2019. The Public Health and Social Services Emergency Fund in H.R. 748, the CARES Act.
Support for S. 2998, the Tax Payment Clarification Act.
Ambulatory Surgical Center Quality and Access Act of 2019
Client: AMBULATORY SURGERY CENTER ASSOCIATION · Firm: THE MCMANUS GROUP
Support for H.R.4350/S. 3085, The Ambulatory Surgical Center Quality and Access Act of 2019, and legislation to tie ambulatory surgery center payment updates to the hospital market basket. H.R. 3429, the HEARTS and Rural Relief Act of 2019. Increase patient access to procedures in ASCs. Implementation of the Public Health and Social Services Emergency Fund provision in H.R. 748. Discontinuance of ASC relative weight scalar.
Ambulatory Surgical Center Quality and Access Act of 2019
Client: AMBULATORY SURGERY CENTER ASSOCIATION · Firm: THE MCMANUS GROUP
Support for H.R.4350/S. 3085, The Ambulatory Surgical Center Quality and Access Act of 2019, and legislation to tie ambulatory surgery center payment updates to the hospital market basket. H.R. 3429, the HEARTS and Rural Relief Act of 2019. Increase patient access to procedures in ASCs. The Public Health and Social Services Emergency Fund provision in H.R. 748, the CARES Act.
Ambulatory Surgical Center Quality and Access Act of 2019
Client: AMBULATORY SURGERY CENTER ASSOCIATION · Firm: THE MCMANUS GROUP
Support for H.R.4350/S. 3085, The Ambulatory Surgical Center Quality and Access Act of 2019, and legislation to tie ambulatory surgery center payment updates to the hospital market basket. H.R. 3429, the HEARTS and Rural Relief Act of 2019. Increase patient access to procedures in ASCs. The Public Health and Social Services Emergency Fund provision in H.R. 748, the CARES Act, as well as S. 3559/ H.R. 6365, The Immediate Relief for Rural Facilities and Providers Act of 2020.
Lower Costs, More Cures Act of 2019
Client: DENDREON PHARMACEUTICALS LLC · Firm: THE MCMANUS GROUP
Medicare Part B payment reform. S. 2543, the Prescription Drug Pricing Reduction Act of 2019 and S. 3129/H.R. 19, the Lower Costs, More Cures Act of 2019. H.R. 748, the CARES Act. Coronavirus relief waivers.
Lower Costs, More Cures Act of 2019
Client: DIGESTIVE HEALTH PHYSICIANS ASSOCIATION, INC. · Firm: THE MCMANUS GROUP
H.R. 1570 / S. 668 - Removing Barriers to Colorectal Cancer Screening Act of 2019. Opposition to H.R. 2143 - Promoting Integrity in Medicare Act of 2019. Support for H.R. 2282 / S. 966 Medicare Care Coordination Improvement Act of 2019. Opposition to step therapy requirement in Medicare Advantage. Support of proposed rules, Medicare Program; Modernizing and Clarifying the Physician Self-Referral Regulations (84 FR 55766) and Medicare and State Healthcare Programs: Fraud and Abuse; Revisions to Safe Harbors Under the Anti-Kickback Statute, and Civil Monetary Penalty Rules Regarding Beneficiary Inducements (84 FR 55694). S. 2543, the Prescription Drug Pricing Reduction Act of 2019, sec. 102; and S. 3129/H.R. 19, the Lower Costs, More Cures Act of 2019. The Public Health and Social Services Emergency Fund in H.R. 748, the CARES Act.
Lower Costs, More Cures Act of 2019
Client: DENDREON PHARMACEUTICALS LLC · Firm: THE MCMANUS GROUP
Medicare Part B payment reform. S. 2543, the Prescription Drug Pricing Reduction Act of 2019 and S. 3129/H.R. 19, the Lower Costs, More Cures Act of 2019. H.R. 748, the CARES Act.
Lower Costs, More Cures Act of 2019
Client: DENDREON PHARMACEUTICALS LLC · Firm: THE MCMANUS GROUP
Medicare Part B payment reform. S. 2543, the Prescription Drug Pricing Reduction Act of 2019 and S. 3129/H.R. 19, the Lower Costs, More Cures Act of 2019. H.R. 748, the CARES Act. Coronavirus relief waivers.
Lower Costs, More Cures Act of 2019
Client: DIGESTIVE HEALTH PHYSICIANS ASSOCIATION, INC. · Firm: THE MCMANUS GROUP
H.R. 1570 / S. 668 - Removing Barriers to Colorectal Cancer Screening Act of 2019. Opposition to H.R. 2143 - Promoting Integrity in Medicare Act of 2019. Support for H.R. 2282 / S. 966 Medicare Care Coordination Improvement Act of 2019. Opposition to step therapy requirement in Medicare Advantage. Support of proposed rules, Medicare Program; Modernizing and Clarifying the Physician Self-Referral Regulations (84 FR 55766) and Medicare and State Healthcare Programs: Fraud and Abuse; Revisions to Safe Harbors Under the Anti-Kickback Statute, and Civil Monetary Penalty Rules Regarding Beneficiary Inducements (84 FR 55694). S. 2543, the Prescription Drug Pricing Reduction Act of 2019, sec. 102; and S. 3129/H.R. 19, the Lower Costs, More Cures Act of 2019. The Public Health and Social Services Emergency Fund in H.R. 748, the CARES Act, and S. 3559/H.R. 6365, the Immediate Relief for Rural Facilities and Providers Act.
Lower Costs, More Cures Act of 2019
Client: DIGESTIVE HEALTH PHYSICIANS ASSOCIATION, INC. · Firm: THE MCMANUS GROUP
H.R. 1570 / S. 668 - Removing Barriers to Colorectal Cancer Screening Act of 2019. Opposition to H.R. 2143 - Promoting Integrity in Medicare Act of 2019. Support for H.R. 2282 / S. 966 Medicare Care Coordination Improvement Act of 2019. Opposition to step therapy requirement in Medicare Advantage. Support of proposed rules, Medicare Program; Modernizing and Clarifying the Physician Self-Referral Regulations (84 FR 55766) and Medicare and State Healthcare Programs: Fraud and Abuse; Revisions to Safe Harbors Under the Anti-Kickback Statute, and Civil Monetary Penalty Rules Regarding Beneficiary Inducements (84 FR 55694). S. 2543, the Prescription Drug Pricing Reduction Act of 2019, sec. 102; and S. 3129/H.R. 19, the Lower Costs, More Cures Act of 2019. The Public Health and Social Services Emergency Fund in H.R. 748, the CARES Act.
Lower Costs, More Cures Act of 2019
Client: DENDREON PHARMACEUTICALS LLC · Firm: THE MCMANUS GROUP
Medicare Part B payment reform. S. 2543, the Prescription Drug Pricing Reduction Act of 2019 and S. 3129/H.R. 19, the Lower Costs, More Cures Act of 2019. H.R. 748, the CARES Act.
Lower Costs, More Cures Act of 2019
Client: DIGESTIVE HEALTH PHYSICIANS ASSOCIATION, INC. · Firm: THE MCMANUS GROUP
H.R. 1570 / S. 668 - Removing Barriers to Colorectal Cancer Screening Act of 2019. Opposition to H.R. 2143 - Promoting Integrity in Medicare Act of 2019. Support for H.R. 2282 / S. 966 Medicare Care Coordination Improvement Act of 2019. Opposition to step therapy requirement in Medicare Advantage. Support of proposed rules, Medicare Program; Modernizing and Clarifying the Physician Self-Referral Regulations (84 FR 55766) and Medicare and State Healthcare Programs: Fraud and Abuse; Revisions to Safe Harbors Under the Anti-Kickback Statute, and Civil Monetary Penalty Rules Regarding Beneficiary Inducements (84 FR 55694). S. 2543, the Prescription Drug Pricing Reduction Act of 2019, sec. 102; and S. 3129/H.R. 19, the Lower Costs, More Cures Act of 2019. Implementation of the Public Health and Social Services Emergency Fund in H.R. 748.
Immediate Relief for Rural Facilities and Providers Act of 2020
Client: DIGESTIVE HEALTH PHYSICIANS ASSOCIATION, INC. · Firm: THE MCMANUS GROUP
H.R. 1570 / S. 668 - Removing Barriers to Colorectal Cancer Screening Act of 2019. Opposition to H.R. 2143 - Promoting Integrity in Medicare Act of 2019. Support for H.R. 2282 / S. 966 Medicare Care Coordination Improvement Act of 2019. Opposition to step therapy requirement in Medicare Advantage. Support of proposed rules, Medicare Program; Modernizing and Clarifying the Physician Self-Referral Regulations (84 FR 55766) and Medicare and State Healthcare Programs: Fraud and Abuse; Revisions to Safe Harbors Under the Anti-Kickback Statute, and Civil Monetary Penalty Rules Regarding Beneficiary Inducements (84 FR 55694). S. 2543, the Prescription Drug Pricing Reduction Act of 2019, sec. 102; and S. 3129/H.R. 19, the Lower Costs, More Cures Act of 2019. The Public Health and Social Services Emergency Fund in H.R. 748, the CARES Act, and S. 3559/H.R. 6365, the Immediate Relief for Rural Facilities and Providers Act.
Immediate Relief for Rural Facilities and Providers Act of 2020
Client: AMBULATORY SURGERY CENTER ASSOCIATION · Firm: THE MCMANUS GROUP
S. 3559/ H.R. 6365, The Immediate Relief for Rural Facilities and Providers Act of 2020.
Immediate Relief for Rural Facilities and Providers Act of 2020
Client: AMBULATORY SURGERY CENTER ASSOCIATION · Firm: THE MCMANUS GROUP
S. 3559/ H.R. 6365, The Immediate Relief for Rural Facilities and Providers Act of 2020.
Immediate Relief for Rural Facilities and Providers Act of 2020
Client: AMBULATORY SURGERY CENTER ASSOCIATION · Firm: THE MCMANUS GROUP
Support for H.R.4350/S. 3085, The Ambulatory Surgical Center Quality and Access Act of 2019, and legislation to tie ambulatory surgery center payment updates to the hospital market basket. H.R. 3429, the HEARTS and Rural Relief Act of 2019. Increase patient access to procedures in ASCs. The Public Health and Social Services Emergency Fund provision in H.R. 748, the CARES Act, as well as S. 3559/ H.R. 6365, The Immediate Relief for Rural Facilities and Providers Act of 2020.
Removing Barriers to Colorectal Cancer Screening Act of 2019
Client: DIGESTIVE HEALTH PHYSICIANS ASSOCIATION, INC. · Firm: THE MCMANUS GROUP
H.R. 1570 / S. 668 - Removing Barriers to Colorectal Cancer Screening Act of 2019. Opposition to H.R. 2143 - Promoting Integrity in Medicare Act of 2019. Support for H.R. 2282 / S. 966 Medicare Care Coordination Improvement Act of 2019. Opposition to step therapy requirement in Medicare Advantage. Support of proposed rules, Medicare Program; Modernizing and Clarifying the Physician Self-Referral Regulations (84 FR 55766) and Medicare and State Healthcare Programs: Fraud and Abuse; Revisions to Safe Harbors Under the Anti-Kickback Statute, and Civil Monetary Penalty Rules Regarding Beneficiary Inducements (84 FR 55694). S. 2543, the Prescription Drug Pricing Reduction Act of 2019, sec. 102; and S. 3129/H.R. 19, the Lower Costs, More Cures Act of 2019. The Public Health and Social Services Emergency Fund in H.R. 748, the CARES Act.
2020 · first_quarter · 1A
H.R. 1570 / S. 668 - Removing Barriers to Colorectal Cancer Screening Act of 2019. Opposition to H.R. 2143 - Promoting Integrity in Medicare Act of 2019. Support for H.R. 2282 / S. 966 Medicare Care Coordination Improvement Act of 2019. Opposition to step therapy requirement in Medicare Advantage. Support of proposed rules, Medicare Program; Modernizing and Clarifying the Physician Self-Referral Regulations (84 FR 55766) and Medicare and State Healthcare Programs: Fraud and Abuse; Revisions to Safe Harbors Under the Anti-Kickback Statute, and Civil Monetary Penalty Rules Regarding Beneficiary Inducements (84 FR 55694). S. 2543, the Prescription Drug Pricing Reduction Act of 2019, sec. 102; and S. 3129/H.R. 19, the Lower Costs, More Cures Act of 2019. The Public Health and Social Services Emergency Fund in H.R. 748, the CARES Act.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NATIONAL ASSOCIATION OF FREESTANDING EMERGENCY CENTERS (NAFEC) via THE MCMANUS GROUP
2020 · third_quarter · 3A
Requirements related to COVID-19 testing. Surprise billing reform, including S. 1895, the Lower Health Care Costs Act, H.R. 3630, the No Surprises Act, H.R. 5826, the Consumer Protections Against Surprise Medical Bills Act, and H.R. 5800, the Ban Surprise Bills Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NATIONAL ASSOCIATION OF FREESTANDING EMERGENCY CENTERS (NAFEC) via THE MCMANUS GROUP
2020 · third_quarter · Q3
Requirements related to COVID-19 testing. Surprise billing reform, including S. 1895, the Lower Health Care Costs Act, H.R. 3630, the No Surprises Act, H.R. 5826, the Consumer Protections Against Surprise Medical Bills Act, and H.R. 5800, the Ban Surprise Bills Act.
Education and advocacy regarding emergency services and Medicare reimbursement of freestanding emergency centers, including CMS-1744-IFC, and CMS-5531-IFC.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
IVX HEALTH via THE MCMANUS GROUP
2020 · second_quarter · 2T
Distribution changes in the private market.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
DENDREON PHARMACEUTICALS LLC via THE MCMANUS GROUP
2020 · second_quarter · 2A
Medicare Part B payment reform. S. 2543, the Prescription Drug Pricing Reduction Act of 2019 and S. 3129/H.R. 19, the Lower Costs, More Cures Act of 2019. H.R. 748, the CARES Act. Coronavirus relief waivers.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
DENDREON PHARMACEUTICALS LLC via THE MCMANUS GROUP
2020 · first_quarter · 1A
Medicare Part B payment reform. S. 2543, the Prescription Drug Pricing Reduction Act of 2019 and S. 3129/H.R. 19, the Lower Costs, More Cures Act of 2019. H.R. 748, the CARES Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMBULATORY SURGERY CENTER ASSOCIATION via THE MCMANUS GROUP
2020 · second_quarter · Q2
Implementation of the Paycheck Protection Program and H.R. 7010/ S. 38015, the Paycheck Protection Program Flexibility Act.
Support for H.R.4350/S. 3085, The Ambulatory Surgical Center Quality and Access Act of 2019, and legislation to tie ambulatory surgery center payment updates to the hospital market basket. H.R. 3429, the HEARTS and Rural Relief Act of 2019. Increase patient access to procedures in ASCs. Implementation of the Public Health and Social Services Emergency Fund provision in H.R. 748. Discontinuance of ASC relative weight scalar.
S. 3559/ H.R. 6365, The Immediate Relief for Rural Facilities and Providers Act of 2020.
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via THE MCMANUS GROUP
2020 · second_quarter · Q2
Reforms related to the pharmaceutical supply chain.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DENDREON PHARMACEUTICALS LLC via THE MCMANUS GROUP
2020 · second_quarter · Q2
Medicare Part B payment reform. S. 2543, the Prescription Drug Pricing Reduction Act of 2019 and S. 3129/H.R. 19, the Lower Costs, More Cures Act of 2019. H.R. 748, the CARES Act. Coronavirus relief waivers.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICAN OCCUPATIONAL THERAPY ASSOCIATION via THE MCMANUS GROUP
2020 · second_quarter · Q2
Support for reform of OT opening cases in home health. H.R. 3127/S. 1725, the Medicare Home Health Flexibility Act. Implementation of Physician Fee Schedule in 84 FR 62568. Implementation of the Public Health and Social Services Emergency Fund provision in H.R. 748. Medicare telehealth expansion in CMS-1744-IFC and CMS-5531-IFC
Implementation of the Paycheck Protection Program.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE
WEX HEALTH via THE MCMANUS GROUP
2020 · second_quarter · Q2
S. 12 - Health Savings Act of 2019. Inclusion of COBRA provision in coronavirus relief legislation. Issues related to to Pandemic Health Accounts.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE
DIGESTIVE HEALTH PHYSICIANS ASSOCIATION, INC. via THE MCMANUS GROUP
2020 · second_quarter · Q2
H.R. 1570 / S. 668 - Removing Barriers to Colorectal Cancer Screening Act of 2019. Opposition to H.R. 2143 - Promoting Integrity in Medicare Act of 2019. Support for H.R. 2282 / S. 966 Medicare Care Coordination Improvement Act of 2019. Opposition to step therapy requirement in Medicare Advantage. Support of proposed rules, Medicare Program; Modernizing and Clarifying the Physician Self-Referral Regulations (84 FR 55766) and Medicare and State Healthcare Programs: Fraud and Abuse; Revisions to Safe Harbors Under the Anti-Kickback Statute, and Civil Monetary Penalty Rules Regarding Beneficiary Inducements (84 FR 55694). S. 2543, the Prescription Drug Pricing Reduction Act of 2019, sec. 102; and S. 3129/H.R. 19, the Lower Costs, More Cures Act of 2019. Implementation of the Public Health and Social Services Emergency Fund in H.R. 748.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ZIMMER BIOMET via THE MCMANUS GROUP
2020 · second_quarter · Q2
Support for S. 2998, the Tax Payment Clarification Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION OF FREESTANDING EMERGENCY CENTERS (NAFEC) via THE MCMANUS GROUP
2020 · second_quarter · Q2
Education and advocacy regarding emergency services and Medicare reimbursement of freestanding emergency centers, including CMS-1744-IFC, and CMS-5531-IFC.
Surprise billing reform, including S. 1895, the Lower Health Care Costs Act, H.R. 3630, the No Surprises Act, H.R. 5826, the Consumer Protections Against Surprise Medical Bills Act, and H.R. 5800, the Ban Surprise Bills Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
IVX HEALTH via THE MCMANUS GROUP
2020 · second_quarter · Q2
Distribution changes in the private market.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NASH ALLIANCE LLC via THE MCMANUS GROUP
2020 · first_quarter · 1T
Policies regarding research, education, and prevention activities relating to nonalcoholic steatohepatitis.
Support for research, education, and prevention activities relating to nonalcoholic steatohepatitis.
Filing targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, SENATE, White House Office
ANTIMICROBIAL INNOVATION ALLIANCE via THE MCMANUS GROUP
2020 · first_quarter · 1T
Development of policies to advance the antimicrobial research and novel product development environment, including advancing new market incentives.
Medicare payment for inpatient antibiotics.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION OF FREESTANDING EMERGENCY CENTERS (NAFEC) via THE MCMANUS GROUP
2020 · first_quarter · Q1
Education and advocacy regarding emergency services and Medicare reimbursement of freestanding emergency centers, including H.R. 748, the CARES Act, and CMS-1744-IFC.
Surprise billing reform, including S. 1895, the Lower Health Care Costs Act, H.R. 3630, the No Surprises Act, H.R. 5826, the Consumer Protections Against Surprise Medical Bills Act, and H.R. 5800, the Ban Surprise Bills Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
DIGESTIVE HEALTH PHYSICIANS ASSOCIATION, INC. via THE MCMANUS GROUP
2020 · first_quarter · 1A
H.R. 1570 / S. 668 - Removing Barriers to Colorectal Cancer Screening Act of 2019. Opposition to H.R. 2143 - Promoting Integrity in Medicare Act of 2019. Support for H.R. 2282 / S. 966 Medicare Care Coordination Improvement Act of 2019. Opposition to step therapy requirement in Medicare Advantage. Support of proposed rules, Medicare Program; Modernizing and Clarifying the Physician Self-Referral Regulations (84 FR 55766) and Medicare and State Healthcare Programs: Fraud and Abuse; Revisions to Safe Harbors Under the Anti-Kickback Statute, and Civil Monetary Penalty Rules Regarding Beneficiary Inducements (84 FR 55694). S. 2543, the Prescription Drug Pricing Reduction Act of 2019, sec. 102; and S. 3129/H.R. 19, the Lower Costs, More Cures Act of 2019. The Public Health and Social Services Emergency Fund in H.R. 748, the CARES Act.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMBULATORY SURGERY CENTER ASSOCIATION via THE MCMANUS GROUP
2020 · first_quarter · 1A
Support for H.R.4350/S. 3085, The Ambulatory Surgical Center Quality and Access Act of 2019, and legislation to tie ambulatory surgery center payment updates to the hospital market basket. H.R. 3429, the HEARTS and Rural Relief Act of 2019. Increase patient access to procedures in ASCs. The Public Health and Social Services Emergency Fund provision in H.R. 748, the CARES Act.
The Paycheck Protection Program in H.R. 748, the CARES Act.
S. 3559/ H.R. 6365, The Immediate Relief for Rural Facilities and Providers Act of 2020.
DIGESTIVE HEALTH PHYSICIANS ASSOCIATION, INC. via THE MCMANUS GROUP
2020 · first_quarter · Q1
H.R. 1570 / S. 668 - Removing Barriers to Colorectal Cancer Screening Act of 2019. Opposition to H.R. 2143 - Promoting Integrity in Medicare Act of 2019. Support for H.R. 2282 / S. 966 Medicare Care Coordination Improvement Act of 2019. Opposition to step therapy requirement in Medicare Advantage. Support of proposed rules, Medicare Program; Modernizing and Clarifying the Physician Self-Referral Regulations (84 FR 55766) and Medicare and State Healthcare Programs: Fraud and Abuse; Revisions to Safe Harbors Under the Anti-Kickback Statute, and Civil Monetary Penalty Rules Regarding Beneficiary Inducements (84 FR 55694). S. 2543, the Prescription Drug Pricing Reduction Act of 2019, sec. 102; and S. 3129/H.R. 19, the Lower Costs, More Cures Act of 2019. The Public Health and Social Services Emergency Fund in H.R. 748, the CARES Act, and S. 3559/H.R. 6365, the Immediate Relief for Rural Facilities and Providers Act.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
DENDREON PHARMACEUTICALS LLC via THE MCMANUS GROUP
2020 · first_quarter · Q1
Medicare Part B payment reform. S. 2543, the Prescription Drug Pricing Reduction Act of 2019 and S. 3129/H.R. 19, the Lower Costs, More Cures Act of 2019. H.R. 748, the CARES Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMBULATORY SURGERY CENTER ASSOCIATION via THE MCMANUS GROUP
2020 · first_quarter · Q1
The Paycheck Protection Program in H.R. 748, the CARES Act.
Support for H.R.4350/S. 3085, The Ambulatory Surgical Center Quality and Access Act of 2019, and legislation to tie ambulatory surgery center payment updates to the hospital market basket. H.R. 3429, the HEARTS and Rural Relief Act of 2019. Increase patient access to procedures in ASCs. The Public Health and Social Services Emergency Fund provision in H.R. 748, the CARES Act, as well as S. 3559/ H.R. 6365, The Immediate Relief for Rural Facilities and Providers Act of 2020.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Small Business Administration (SBA), Treasury, Dept of
AMERICAN OCCUPATIONAL THERAPY ASSOCIATION via THE MCMANUS GROUP
2020 · first_quarter · Q1
The Paycheck Protection Program in H.R. 748, the CARES Act.
Support for reform of OT opening cases in home health. H.R. 3127/S. 1725, the Medicare Home Health Flexibility Act. Implementation of Physician Fee Schedule in 84 FR 62568. The Public Health and Social Services Emergency Fund provision in H.R. 748, the CARES Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
WEX HEALTH via THE MCMANUS GROUP
2020 · first_quarter · Q1
S. 12 - Health Savings Act of 2019. Inclusion of COBRA provision in H.R. 748, the CARES Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DENDREON PHARMACEUTICALS LLC via THE MCMANUS GROUP
2019 · fourth_quarter · 4A
Medicare Part B payment reform. S. 2543, the Prescription Drug Pricing Reduction Act of 2019 and H.R. 19, the Lower Costs, More Cures Act of 2019.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DENDREON PHARMACEUTICALS LLC via THE MCMANUS GROUP
2019 · third_quarter · 3A
Medicare Part B payment reform. S. 2543, the Prescription Drug Pricing Reduction Act of 2019, and H.R. 3, the Lower Drug Costs Now Act of 2019.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NASH ALLIANCE LLC via THE MCMANUS GROUP
2019 · fourth_quarter · Q4
Support for research, education, and prevention activities relating to nonalcoholic steatohepatitis.
Policies regarding research, education, and prevention activities relating to nonalcoholic steatohepatitis.
Filing targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, SENATE, White House Office
ANTIMICROBIAL INNOVATION ALLIANCE via THE MCMANUS GROUP
2019 · fourth_quarter · Q4
Development of policies to advance the antimicrobial research and novel product development environment, including advancing new market incentives.
Medicare payment for inpatient antibiotics.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
WEX HEALTH via THE MCMANUS GROUP
2019 · fourth_quarter · Q4
S. 12 - Health Savings Act of 2019. Support for Cadillac Tax repeal in H.R. 748/S. 684, the Middle Class Health Benefits Tax Repeal Act of 2019. Support S. 1089/H.R. 1922 - the Restoring Access to Medication Act of 2019. Support for Cadillac Tax repeal in H.R. 1865, the Further Consolidated Appropriations Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION OF FREESTANDING EMERGENCY CENTERS (NAFEC) via THE MCMANUS GROUP
2019 · fourth_quarter · Q4
Education and advocacy regarding emergency services and Medicare reimbursement of freestanding emergency centers.
Surprise billing reform, including H.R 3630, the No Surprises Act, and S. 1895, the Lower Health Care Costs Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DENDREON PHARMACEUTICALS LLC via THE MCMANUS GROUP
2019 · fourth_quarter · Q4
Medicare Part B payment reform. S. 2543, the Prescription Drug Pricing Reduction Act of 2019 and H.R. 19, the Lower Costs, More Cures Act of 2019.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DENDREON PHARMACEUTICALS LLC via THE MCMANUS GROUP
2019 · third_quarter · Q3
Medicare Part B payment reform. S. 2543, the Prescription Drug Pricing Reduction Act of 2019, and H.R. 3, the Lower Drug Costs Now Act of 2019.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION OF FREESTANDING EMERGENCY CENTERS (NAFEC) via THE MCMANUS GROUP
2019 · third_quarter · Q3
Education and advocacy regarding emergency services and Medicare reimbursement of freestanding emergency centers.
Support for surprise billing reform, including H.R 3630, the No Surprises Act, and S. 1895, the Lower Health Care Costs Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION OF FREESTANDING EMERGENCY CENTERS (NAFEC) via THE MCMANUS GROUP
2019 · third_quarter · Q3
Education and advocacy regarding emergency services and Medicare reimbursement of freestanding emergency centers.
Support for surprise billing reform, including H.R 3630, the No Surprises Act, and S. 1895, the Lower Health Care Costs Act; and
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DIGESTIVE HEALTH PHYSICIANS ASSOCIATION, INC. via THE MCMANUS GROUP
2019 · third_quarter · Q3
H.R. 1570 / S. 668 - Removing Barriers to Colorectal Cancer Screening Act of 2019. Opposition to H.R. 2143 - Promoting Integrity in Medicare Act of 2019. Support for H.R. 2282 / S. 966 Medicare Care Coordination Improvement Act of 2019. Opposition to step therapy requirement in Medicare Advantage. Commented on Stark Law RFI, CMS-1720-NC regarding the physician self-referral law. S. 2543, the Prescription Drug Pricing Reduction Act of 2019, sec. 102.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
WEX HEALTH via THE MCMANUS GROUP
2019 · third_quarter · Q3
S. 12 - Health Savings Act of 2019. Support for Cadillac Tax repeal in H.R. 748/S. 684, the Middle Class Health Benefits Tax Repeal Act of 2019. Support S. 1089/H.R. 1922 - the Restoring Access to Medication Act of 2019.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ANTIMICROBIAL INNOVATION ALLIANCE via THE MCMANUS GROUP
2019 · third_quarter · Q3
Medicare payment for inpatient antibiotics.
Development of policies to advance the antimicrobial research and novel product development environment, including advancing new market incentives.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NASH ALLIANCE LLC via THE MCMANUS GROUP
2019 · third_quarter · Q3
Policies regarding research, education, and prevention activities relating to nonalcoholic steatohepatitis.
Support for research, education, and prevention activities relating to nonalcoholic steatohepatitis.
Filing targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, SENATE, White House Office
NASH ALLIANCE LLC via THE MCMANUS GROUP
2019 · second_quarter · 2A
Policies regarding research, education, and prevention activities relating to nonalcoholic steatohepatitis.
Support for research, education, and prevention activities relating to nonalcoholic steatohepatitis.
Filing targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, SENATE, White House Office
NASH ALLIANCE LLC via THE MCMANUS GROUP
2019 · first_quarter · 1A
Support for research, education, and prevention activities relating to nonalcoholic steatohepatitis.
Filing targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, SENATE
NASH ALLIANCE LLC via THE MCMANUS GROUP
2019 · first_quarter · RR
Issues regarding non-alcoholic steatohepatitis and non-alcoholic fatty liver disease.
Issues regarding non-alcoholic steatohepatitis and non-alcoholic fatty liver disease.
Issues regarding non-alcoholic steatohepatitis and non-alcoholic fatty liver disease.
ANTIMICROBIAL INNOVATION ALLIANCE via THE MCMANUS GROUP
2019 · second_quarter · Q2
Medicare payment for inpatient antibiotics.
Development of policies to advance the antimicrobial research and novel product development environment, including advancing new market incentives.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
DIGESTIVE HEALTH PHYSICIANS ASSOCIATION, INC. via THE MCMANUS GROUP
2019 · second_quarter · Q2
H.R. 1570 / S. 668 - Removing Barriers to Colorectal Cancer Screening Act of 2019. Opposition to H.R. 2143 - Promoting Integrity in Medicare Act of 2019. Support for H.R. 2282 / S. 966 Medicare Care Coordination Improvement Act of 2019. Opposition to step therapy requirement in Medicare Advantage. Commented on Stark Law RFI, CMS-1720-NC regarding the physician self-referral law.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
WEX HEALTH via THE MCMANUS GROUP
2019 · second_quarter · Q2
S. 12 - Health Savings Act of 2019. Support for Cadillac Tax repeal in H.R. 748/S. 684, the Middle Class Health Benefits Tax Repeal Act of 2019. Support S. 1089/H.R. 1922 - the Restoring Access to Medication Act of 2019. Support of 84 FR 28888 RIN 1545-BO46.
Filing targets: HOUSE OF REPRESENTATIVES, Natl Economic Council (NEC), SENATE
NATIONAL ASSOCIATION OF FREESTANDING EMERGENCY CENTERS (NAFEC) via THE MCMANUS GROUP
2019 · second_quarter · Q2
Education and advocacy regarding emergency services and Medicare reimbursement of freestanding emergency centers. Support H.R. 2282/S. 966, the Medicare Care Coordination Improvement Act.
Support for surprise billing reform, including H.R. 3502, to amend the Public Health Service Act and title XI of the Social Security Act to protect health care consumers from surprise billing practices, and for other purposes; H.R 3630, the No Surprises Act; S. 1895, the Lower Health Care Costs Act; and S. 1531, the Stopping The Outrageous Practice of Surprise Medical Bills Act of 2019.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ANTIMICROBIAL INNOVATION ALLIANCE via THE MCMANUS GROUP
2019 · first_quarter · Q1
Medicare payment for inpatient antibiotics.
Development of policies to advance the antimicrobial research and novel product development environment, including advancing new market incentives.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
STRAND DIAGNOSTICS via THE MCMANUS GROUP
2019 · first_quarter · Q1
Support for Medicare coverage of prostate cancer diagnostic test.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION OF FREESTANDING EMERGENCY CENTERS (NAFEC) via THE MCMANUS GROUP
2019 · first_quarter · Q1
Support for surprise billing reform.
Education and advocacy regarding emergency services and Medicare reimbursement of freestanding emergency centers.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
LARGE UROLOGY GROUP PRACTICE ASSOCIATION via THE MCMANUS GROUP
2019 · first_quarter · Q1
Support for H.R. 2282 / S. 966 - Medicare Care Coordination Improvement Act of 2019. Opposition to step therapy requirement in Medicare Advantage. CY 2019 OPPS/ ASC Proposed Payment Rule, (83 Fed. Reg. 37046). Lobbied against the International Pricing Index model (83 FR 54546). Support site neutrality proposals. Oppose H.R. 2143 - To prevent wasteful and abusive billing of ancillary services to the Medicare program, and for other purposes.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
WEX HEALTH via THE MCMANUS GROUP
2019 · first_quarter · Q1
S. 12 - Health Savings Act of 2019. Support for Cadillac Tax repeal. Support S. 1089/H.R. 1922 - the Restoring Access to Medication Act of 2019.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DIGESTIVE HEALTH PHYSICIANS ASSOCIATION, INC. via THE MCMANUS GROUP
2019 · first_quarter · Q1
H.R. 1570 / S. 668 - Removing Barriers to Colorectal Cancer Screening Act of 2019. Opposition to H.R. 2143 - Promoting Integrity in Medicare Act of 2019. Support for H.R. 2282 / S. 966 Medicare Care Coordination Improvement Act of 2019. Opposition to step therapy requirement in Medicare Advantage.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN LUNG ASSOCIATION via THE MCMANUS GROUP
2018 · fourth_quarter · Q4
Sec. VII of the proposed rule for the Durable Medical Equipment, Prosthetics, Orthotics, and Supplies Competitive Bidding Program for Calendar Year 2019 (RIN 0938-AT28).
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE
NATIONAL ASSOCIATION OF FREESTANDING EMERGENCY CENTERS (NAFEC) via THE MCMANUS GROUP
2018 · fourth_quarter · Q4
Education and advocacy regarding emergency services and Medicare reimbursement of freestanding emergency centers. Support for S. 3531 - Emergency Care Improvement Act.
Support for surprise billing reform.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ANTIMICROBIAL INNOVATION ALLIANCE via THE MCMANUS GROUP
2018 · fourth_quarter · Q4
Medicare payment for inpatient antibiotics.
Development of policies to advance the antimicrobial research and novel product development environment, including advancing new market incentives. Support for H.R. 6294 - REVAMP Act.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
STRAND DIAGNOSTICS via THE MCMANUS GROUP
2018 · fourth_quarter · Q4
Support for H.R. 2557 / S. 2067 - Prostate Cancer Misdiagnosis Elimination Act of 2017. Support for H.R. 6886 - HEARTS Act of 2018.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DIGESTIVE HEALTH PHYSICIANS ASSOCIATION, INC. via THE MCMANUS GROUP
2018 · fourth_quarter · Q4
H.R. 1017 / S. 479 - Removing Barriers to Colorectal Cancer Screening Act of 2017. Opposition to H.R. 2066 - PIMA of 2017. Support for H.R. 4206 / S. 2051 Medicare Care Coordination Improvement Act of 2017. Opposition to step therapy requirement in Medicare Advantage.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LARGE UROLOGY GROUP PRACTICE ASSOCIATION via THE MCMANUS GROUP
2018 · fourth_quarter · Q4
Support for H.R. 4206 / S. 2051 - Medicare Care Coordination Improvement Act of 2017. Opposition to H.R. 2066 - PIMA of 2017. Opposition to step therapy requirement in Medicare Advantage. CY 2019 OPPS/ ASC Proposed Payment Rule, (83 Fed. Reg. 37046). Lobbied against the International Pricing Index model (83 FR 54546).
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
ACHAOGEN via THE MCMANUS GROUP
2018 · fourth_quarter · 4T
General health care coverage and reimbursement; issues related to infectious disease drug development and procurement; legislative and regulatory issues related to biodefense countermeasure development and procurement; development of policies to advance the antimicrobial research and development environment. Support for H.R. 6294 - REVAMP Act.
Medicare payment for inpatient antibiotics.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
ANTIMICROBIAL INNOVATION ALLIANCE via THE MCMANUS GROUP
2018 · third_quarter · Q3
Development of policies to advance the antimicrobial research and novel product development environment, including advancing new market incentives. Support for H.R. 6294 - REVAMP Act.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), Office of Personnel Management (OPM), SENATE
AMERICAN LUNG ASSOCIATION via THE MCMANUS GROUP
2018 · third_quarter · Q3
Sec. VII of the proposed rule for the Durable Medical Equipment, Prosthetics, Orthotics, and Supplies Competitive Bidding Program for Calendar Year 2019 (RIN 0938-AT28).
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE
NATIONAL ASSOCIATION OF FREESTANDING EMERGENCY CENTERS (NAFEC) via THE MCMANUS GROUP
2018 · third_quarter · Q3
Education and advocacy regarding emergency services and Medicare reimbursement of freestanding emergency centers. Support for S. 3531 - Emergency Care Improvement Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
STRAND DIAGNOSTICS via THE MCMANUS GROUP
2018 · third_quarter · Q3
Support for H.R. 2557 / S. 2067 - Prostate Cancer Misdiagnosis Elimination Act of 2017. Support for H.R. 6886 - HEARTS Act of 2018.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DIGESTIVE HEALTH PHYSICIANS ASSOCIATION, INC. via THE MCMANUS GROUP
2018 · third_quarter · Q3
H.R. 1017 / S. 479 - Removing Barriers to Colorectal Cancer Screening Act of 2017. Opposition to H.R. 2066 - PIMA of 2017. Support for H.R. 4206 / S. 2051 Medicare Care Coordination Improvement Act of 2017. Opposition to step therapy requirement in Medicare Advantage.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EMD SERONO, INC. via THE MCMANUS GROUP
2018 · third_quarter · Q3
Medicare and Medicaid pharmaceutical coverage and reimbursement issues, particularly regarding neurodegenerative products. Part D reimbursement reform.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ACHAOGEN via THE MCMANUS GROUP
2018 · third_quarter · Q3
General health care coverage and reimbursement; issues related to infectious disease drug development and procurement; legislative and regulatory issues related to biodefense countermeasure development and procurement; development of policies to advance the antimicrobial research and development environment. Support for H.R. 6294 - REVAMP Act.
Medicare payment for inpatient antibiotics.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
LARGE UROLOGY GROUP PRACTICE ASSOCIATION via THE MCMANUS GROUP
2018 · third_quarter · Q3
Support for H.R. 4206 / S. 2051 - Medicare Care Coordination Improvement Act of 2017. Opposition to H.R. 2066 - PIMA of 2017. Opposition to step therapy requirement in Medicare Advantage. CY 2019 OPPS/ ASC Proposed Payment Rule, 83 Fed. Reg. 37046.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
STRAND DIAGNOSTICS via THE MCMANUS GROUP
2018 · second_quarter · Q2
Support for H.R. 2557 / S. 2067 - Prostate Cancer Misdiagnosis Elimination Act of 2017.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION OF FREESTANDING EMERGENCY CENTERS (NAFEC) via THE MCMANUS GROUP
2018 · second_quarter · Q2
Education and advocacy regarding emergency services and Medicare reimbursement of freestanding emergency centers.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LARGE UROLOGY GROUP PRACTICE ASSOCIATION via THE MCMANUS GROUP
2018 · second_quarter · Q2
Support for H.R. 4206 / S. 2051 - Medicare Care Coordination Improvement Act of 2017. Opposition to H.R. 2066 - PIMA of 2017.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
DIGESTIVE HEALTH PHYSICIANS ASSOCIATION, INC. via THE MCMANUS GROUP
2018 · second_quarter · Q2
H.R. 1017 / S. 479 - Removing Barriers to Colorectal Cancer Screening Act of 2017. Opposition to H.R. 2066 - PIMA of 2017. Support for H.R. 4206 / S. 2051 Medicare Care Coordination Improvement Act of 2017.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ACHAOGEN via THE MCMANUS GROUP
2018 · second_quarter · Q2
General health care coverage and reimbursement; issues related to infectious disease drug development and procurement; legislative and regulatory issues related to biodefense countermeasure development and procurement; development of policies to advance the antimicrobial research and development environment. Support for H.R. 6294 - REVAMP Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ANTIMICROBIAL INNOVATION ALLIANCE via THE MCMANUS GROUP
2018 · second_quarter · Q2
Development of policies to advance the antimicrobial research and novel product development environment, including advancing new market incentives. Support for H.R. 6294 - REVAMP Act. Support for antimicrobial incentives to be included in S. 2852 - Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018.
Medicare payment for inpatient antibiotics.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
ANTIMICROBIAL INNOVATION ALLIANCE via THE MCMANUS GROUP
2018 · first_quarter · Q1
Medicare payment for inpatient antibiotics.
Development of policies to advance the antimicrobial research and novel product development environment, including advancing new market incentives.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DIGESTIVE HEALTH PHYSICIANS ASSOCIATION, INC. via THE MCMANUS GROUP
2018 · first_quarter · Q1
H.R. 1017 / S. 479 - Removing Barriers to Colorectal Cancer Screening Act of 2017. Opposition to H.R. 2066 - PIMA of 2017. Support for H.R. 4206 / S. 2051 Medicare Care Coordination Improvement Act of 2017.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LARGE UROLOGY GROUP PRACTICE ASSOCIATION via THE MCMANUS GROUP
2018 · first_quarter · Q1
Support for H.R. 4206 / S. 2051 - Medicare Care Coordination Improvement Act of 2017. Opposition to H.R. 2066 - PIMA of 2017
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
STRAND DIAGNOSTICS via THE MCMANUS GROUP
2018 · first_quarter · Q1
Support for H.R. 2557 / S. 2067 - Prostate Cancer Misdiagnosis Elimination Act of 2017. Support for Medicare coverage of prostate cancer diagnostic test in H.R. 1892 - Bipartisan Budget Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION OF FREESTANDING EMERGENCY CENTERS (NAFEC) via THE MCMANUS GROUP
2018 · first_quarter · Q1
Education and advocacy regarding emergency services and Medicare reimbursement of freestanding emergency centers.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION OF FREESTANDING EMERGENCY CENTERS (NAFEC) via THE MCMANUS GROUP
2017 · fourth_quarter · Q4
Education and advocacy regarding emergency services and Medicare reimbursement of freestanding emergency centers.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
STRAND DIAGNOSTICS via THE MCMANUS GROUP
2017 · fourth_quarter · Q4
Medicare coverage of diagnostic test. Support for H.R. 2557 / S. 2067 - Prostate Cancer Misdiagnosis Elimination Act of 2017.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION OF SPECIALTY PHARMACY (NASP) via THE MCMANUS GROUP
2017 · fourth_quarter · 4T
Education and advocacy regarding drug distribution. H.R. 1038 / S.413 - Improving Transparency and Accuracy in Medicare Part D Spending Act. H.R. 1316 - Prescription Drug Price Transparency Act. Support for S.637 - Creating Transparency to Have Drug Rebates Unlocked (C-THRU) Act of 2017.
Filing targets: HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE
DIGESTIVE HEALTH PHYSICIANS ASSOCIATION, INC. via THE MCMANUS GROUP
2017 · fourth_quarter · Q4
H.R. 1017 / S. 479 - Removing Barriers to Colorectal Cancer Screening Act of 2017. Opposition to H.R. 2066 - PIMA of 2017. Support for H.R. 4206 / S. 2051 Medicare Care Coordination Improvement Act of 2017.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ANTIMICROBIAL INNOVATION ALLIANCE via THE MCMANUS GROUP
2017 · fourth_quarter · Q4
Medicare payment for inpatient antibiotics.
Development of policies to advance the antimicrobial research and novel product development environment, including advancing new market incentives.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ANTIMICROBIAL INNOVATION ALLIANCE via THE MCMANUS GROUP
2017 · third_quarter · Q3
Medicare payment for inpatient antibiotics.
Development of policies to advance the antimicrobial research and novel product development environment, including advancing new market incentives. Advocated to include market incentives for antimicrobials in H.R. 2430 / S. 934 - FDA Reauthorization Act of 2017.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DIGESTIVE HEALTH PHYSICIANS ASSOCIATION, INC. via THE MCMANUS GROUP
2017 · third_quarter · Q3
H.R. 1017 / S. 479 - Removing Barriers to Colorectal Cancer Screening Act of 2017. Support for Stark self referral reform. Opposition to H.R. 2066 - PIMA of 2017.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
STRAND DIAGNOSTICS via THE MCMANUS GROUP
2017 · third_quarter · Q3
Medicare coverage of diagnostic test. Support for H.R. 2557 - Prostate Cancer Misdiagnosis Elimination Act of 2017.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION OF SPECIALTY PHARMACY (NASP) via THE MCMANUS GROUP
2017 · third_quarter · Q3
Education and advocacy regarding drug distribution. H.R. 1038 / S.413 - Improving Transparency and Accuracy in Medicare Part D Spending Act. H.R. 1316 - Prescription Drug Price Transparency Act. Support for S.637 - Creating Transparency to Have Drug Rebates Unlocked (C-THRU) Act of 2017.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
NATIONAL ASSOCIATION OF FREESTANDING EMERGENCY CENTERS (NAFEC) via THE MCMANUS GROUP
2017 · third_quarter · Q3
Education and advocacy regarding emergency services and Medicare reimbursement of freestanding emergency centers.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
STRAND DIAGNOSTICS via THE MCMANUS GROUP
2017 · second_quarter · Q2
Medicare coverage of diagnostic test. Support for H.R. 2557 - Prostate Cancer Misdiagnosis Elimination Act of 2017.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ANTIMICROBIAL INNOVATION ALLIANCE via THE MCMANUS GROUP
2017 · second_quarter · Q2
Development of policies to advance the antimicrobial research and novel product development environment, including advancing new market incentives. Advocated to include market incentives for antimicrobials in H.R. 2430 / S. 934 - FDA Reauthorization Act of 2017.
Medicare payment for inpatient antibiotics.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
STRAND DIAGNOSTICS via THE MCMANUS GROUP
2017 · first_quarter · Q1
Medicare coverage of diagnostic test.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ANTIMICROBIAL INNOVATION ALLIANCE via THE MCMANUS GROUP
2017 · first_quarter · Q1
Development of policies to advance the antimicrobial research and novel product development environment, including advancing new market incentives.
Medicare payment for inpatient antibiotics.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Small Business Administration (SBA), Treasury, Dept of